Loading…
Resources To Prevent Youth Vaping Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Resources to Prevent Youth Vaping Act This bill directs the Food and Drug Administration (FDA) to collect user fees on products that it deems by regulation to be tobacco products, including electronic nicotine delivery systems, and addresses related issues. Currently, the FDA is authorized to collect user fees only on specified classes of tobacco products. The bill increases the total amount of such fees to be collected for FY2022. For each fiscal year after, the total amount of such fees shall be adjusted according to changes in a price index. Starting in FY2024, the FDA must assess user fees on classes of products that it has deemed by regulation to be tobacco products, unless the FDA fails to finalize a formula for assessing such fees on time. Once it is finalized, the FDA may only revise this formula by regulation. The bill also requires each tobacco manufacturer and importer to periodically submit certain information related to the tobacco products that it sells or distributes in the United States. The FDA must annually report to Congress about its use of such tobacco product fees.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2022 · third_quarter · Tobacco
Quit Because of COVID-19 Act (H.R. 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/H.R. 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products FDA nicotine product standard
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $90,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Tobacco
Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products
Client expense: $100,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · first_quarter · Tobacco
Consolidated Appropriations Act, 2022 (Pub.L. 117-103), sections pertaining to FDA authority to regulate synthetic nicotine FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $570,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2022 · fourth_quarter · Tobacco
Quit Because of COVID-19 Act (H.R. 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/H.R. 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA nicotine product standard
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Client expense: Not reported · Firm income: $80,000
2022 · third_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $620,000 · Firm income: Not reported
2022 · third_quarter · Tobacco
Quit Because of COVID-19 Act (H.R. 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/H.R. 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products FDA nicotine product standard
Client expense: $180,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $680,000 · Firm income: Not reported
Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Client expense: Not reported · Firm income: $80,000
2022 · second_quarter · Tobacco
Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products
Client expense: $220,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · first_quarter · Tobacco
Consolidated Appropriations Act, 2022 (Pub.L. 117-103), sections pertaining to FDA authority to regulate synthetic nicotine FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)
Client expense: $200,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · first_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $720,000 · Firm income: Not reported
2021 · fourth_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act H.R. 5546/S. 2974, the PROTECT Act H.R. 6286, the Clarifying Authority over Nicotine Act of 2021
Client expense: $580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Tobacco
FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)
Client expense: $120,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2021 · fourth_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $750,000 · Firm income: Not reported
2021 · third_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Tobacco
FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)
Client expense: $140,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2021 · third_quarter · Tobacco
H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application and Modified Risk Tobacco Product compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products
Client expense: $740,000 · Firm income: Not reported
2021 · third_quarter · Tobacco
Legislation: S. 2599 Senate FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) H.R. 4356 House FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) S. _____ Senate FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 4502 House FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/S. 2622 Quit Because of COVID-19 Act H.R. 2786/S. 1314 Tobacco Tax Equity Act of 2021 H.R. 3226 Accurate Reporting of Smoking Variants Act H.R. 4629/S. 2445 Resources to Prevent Youth Vaping Act H.R. 5376 Build Back Better Act (re tobacco tax & tobacco cessation) H.R. 5546/S. 2974 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. ____ Reversing the Youth Tobacco Epidemic Act Issues: COVID-19 and tobacco E-cigarette marketing FDA action to address menthol cigarettes and flavored cigars FDA regulation of synthetic nicotine FDA regulation of tobacco products FDA review of e-cigarettes Medicaid and tobacco cessation Tobacco and maternal health Tobacco cessation Tobacco taxes Tobacco's role in health disparaties
Client expense: $158,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE